1. Home
  2. GROV vs PDSB Comparison

GROV vs PDSB Comparison

Compare GROV & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grove Collaborative Holdings Inc.

GROV

Grove Collaborative Holdings Inc.

HOLD

Current Price

$1.29

Market Cap

50.9M

ML Signal

HOLD

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$0.95

Market Cap

49.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GROV
PDSB
Founded
2016
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.9M
49.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GROV
PDSB
Price
$1.29
$0.95
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$1.60
$9.00
AVG Volume (30 Days)
37.3K
686.2K
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$180,808,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.63
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$0.70
52 Week High
$1.84
$2.20

Technical Indicators

Market Signals
Indicator
GROV
PDSB
Relative Strength Index (RSI) 56.39 54.58
Support Level $1.18 $0.92
Resistance Level $1.26 $1.02
Average True Range (ATR) 0.06 0.09
MACD 0.02 0.01
Stochastic Oscillator 91.15 51.06

Price Performance

Historical Comparison
GROV
PDSB

About GROV Grove Collaborative Holdings Inc.

Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Share on Social Networks: